GlycoMimetics Long Term Debt 1970-1969 | GLYC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GlycoMimetics long term debt from 1970 to 1969. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GlycoMimetics long term debt from 1970 to 1969. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$79.5B
Zoetis (ZTS)	$68B
Daiichi Sankyo, - (DSNKY)	$46.9B
Takeda Pharmaceutical (TAK)	$46.6B
BeOne Medicines - (ONC)	$32.5B
Sandoz Group AG (SDZNY)	$26.5B
Summit Therapeutics (SMMT)	$20.5B
Merck (MKKGY)	$17.3B
Shionogi (SGIOY)	$14.6B
United Therapeutics (UTHR)	$13.8B
Neurocrine Biosciences (NBIX)	$13B
Orion OYJ (ORINY)	$11.7B
IPSEN (IPSEY)	$11.1B
Stevanato Group S.p.A (STVN)	$8.5B
Corcept Therapeutics (CORT)	$7.2B
Grifols, S.A (GRFS)	$6.8B
Ionis Pharmaceuticals (IONS)	$6.7B
Madrigal Pharmaceuticals (MDGL)	$6.6B
Hikma Pharmaceuticals Plc (HKMPF)	$6.2B
Ono Pharmaceutical (OPHLF)	$5.2B
Soleno Therapeutics (SLNO)	$4.4B
Hypermarcas (HYPMY)	$3.1B
Crinetics Pharmaceuticals (CRNX)	$2.8B
NewAmsterdam Pharma (NAMS)	$2.6B
Catalyst Pharmaceuticals (CPRX)	$2.6B
Procaps Group, S.A (PROCF)	$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.5B
Centessa Pharmaceuticals (CNTA)	$2.1B
Ocular Therapeutix (OCUL)	$1.9B
BioCryst Pharmaceuticals (BCRX)	$1.8B